Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

electroCore to Present at the Two December Investor Conferences

November 26, 2019 at 4:05 PM EST

BASKING RIDGE, N.J., Nov. 26, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, Chief Executive Officer, will present  a corporate overview and host investor meetings at the Evercore ISI HealthCONx  Conference 2019, taking place December 2-4, 2019 at Four Seasons Hotel in Boston, Massachusetts, and the LD Micro 12th Annual Main Event conference, taking place December 10-12, 2019 at the Luxe Sunset in Bel-Air, California. 

 
Evercore ISI HealthCONx Conference 2019
Date: Wednesday, December 4
Time:  8:45am Eastern Time
Location:  Four Seasons Hotel, Boston, Massachusetts


LD Micro 12th Annual Main Event
Date: Wednesday, December 11
Time:  1:00pm Pacific Time
Location:  Luxe Sunset Hotel, Bel-Air, California


About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:

Hans VitzthumLifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:

Sara Zelkovic
LifeSci Public Relations
646-876-4933
sara@lifescipublicrelations.com

EC-Logo-2018_TM_CMYK.jpg